相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
Christian M. Zechmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2
Rene Martin et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A-DTPA-DUPA-Pep
Benjamin Baur et al.
PHARMACEUTICALS (2014)
Phase II Study of Lutetium-177-Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer
Scott T. Tagawa et al.
CLINICAL CANCER RESEARCH (2013)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Simplified NaCl Based 68Ga Concentration and Labeling Procedure for Rapid Synthesis of 68Ga Radiopharmaceuticals in High Radiochemical Purity
Dirk Mueller et al.
BIOCONJUGATE CHEMISTRY (2012)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
DOTAGA-Anhydride: A Valuable Building Block for the Preparation of DOTA-Like Chelating Agents
Claire Bernhard et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
A Monoreactive Bifunctional Triazacyclononane Phosphinate Chelator with High Selectivity for Gallium-68
Jakub Simecek et al.
CHEMMEDCHEM (2012)
Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
Steve Y. Cho et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Prostate-Specific Membrane Antigen-Based Therapeutics
Naveed H. Akhtar et al.
ADVANCES IN UROLOGY (2012)
TRAP, a Powerful and Versatile Framework for Gallium-68 Radiopharmaceuticals
Johannes Notni et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Sangeeta Ray Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small Molecules
Andrew X. Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
Shawn M. Hillier et al.
CANCER RESEARCH (2009)
A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
K. P. Maresca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents
Sumith A. Kularatne et al.
MOLECULAR PHARMACEUTICS (2009)
N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC:: A new imaging probe for prostate cancer
Ronnie C. Mease et al.
CLINICAL CANCER RESEARCH (2008)
Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)
Sangeeta R. Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer
Ying Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors
Matthew I. Milowsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
JR Mesters et al.
EMBO JOURNAL (2006)
Preparation of N-succinimidyl 3-[*I] iodobenzoate: an agent for the indirect radioiodination of proteins
Ganesan Vaidyanathan et al.
NATURE PROTOCOLS (2006)
Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
CA Foss et al.
CLINICAL CANCER RESEARCH (2005)
Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124
B Dekker et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide:: Effect on cellular ligand trafficking in vitro and tumor accumulation in vivo
M Schottelius et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A Ghosh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer
MI Milowsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
N Schülke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
11C-MCG: Synthesis, Uptake Selectivity, and Primate PET of a Probe for Glutamate Carboxypeptidase II (NAALADase)
Martin G. Pomper et al.
MOLECULAR IMAGING (2002)
Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)
AP Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labelling
KP Eisenwiener et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
分享论文
